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AAPM Annual Meeting

Measuring Pacemaker Dose:
A Clinical Perspective
Studenski, M., Xiao, Y., Harrison, A.
Department of Radiation Oncology, Thomas Jefferson University and Hospitals, Philadelphia, PA

Purpose

Conclusion

The number of patients presenting with pacemakers in our clinic has
increased recently. Following AAPM recommendations, a treatment
plan is developed that minimizes the dose to the pacemaker. The
most efficient way to measure in vivo dose during treatment is to
use MOSFETs or diodes which offer a simple but inaccurate (up to
25% error) method of recording. In this abstract, we analyze the
dose measured by these different devices in an attempt to assess
pacemaker dose.

The simplest and most efficient in vivo measurement is to use a
MOSFET or diode. When the pacemaker is more than 20 cm from
the field edge these dosimeters are appropriate. When the field is less
than 20 cm away, the most accurate although inefficient method is to
use an ion chamber since there is little angular or energy dependence
unlike diodes or MOSFETs. Another solution would be to use TLDs
or OSL dosimeters although these are not simplistic dosimeters either.

Method and Materials
Five patients with different disease sites and pacemakers were chosen.
To simulate the treatment delivery, a Rando phantom was placed on
the table in the patient treatment position. An ion chamber was taped
to the phantom under 1 cm bolus. Two MOSFETs and a diode were
placed on top of the bolus and the treatment was delivered. One cone
beam CT was obtained where the pacemaker was in the field-of-view
to quantify the MOSFET and diode reading in this situation.

Results
The measurement from the ion chamber agreed well with the
predicted dose from the planning system. Some errors resulted from
misalignment of the phantom and ion chamber. Both the MOSFET
and diode measurements agreed with the ion chamber and TPS
with greater distances. Dose from CBCT was overestimated for both
MOSFETs and diodes.
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